13 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PPH Saliva Collection Kit

FDA 510(k)
FDA Class 2 ·Microbiology

IPACS MEDICAL IMAGE MANAGEMENT SYSTEM

FDA 510(k)
FDA Class 2 ·Radiology

BRITESMILE MASKING CREAM

FDA 510(k)
FDA Class 1 ·Dental

IMP,TSV,MCOL MG,4.7MM,10M

FDA Adverse Event
Injury ·ZIMMER DENTAL·Product code DZE·November 16, 2021

IMP,TSV,MCOL MG,4.1MM,10M

FDA Adverse Event
Injury ·ZIMMER DENTAL·Product code DZE·November 16, 2021

TERA HARZ CLEAR

FDA Adverse Event
Injury ·GRAPHY INC.·Product code NXC·June 16, 2025

TERA HARZ CLEAR

FDA Adverse Event
Injury ·GRAPHY INC.·Product code NXC·June 16, 2025

TERA HARZ CLEAR

FDA Adverse Event
Injury ·GRAPHY INC.·Product code NXC·June 16, 2025

MECHANICAL (MANUAL) WHEELCHAIR

FDA Adverse Event
JUMAO HEALTHCARE EQUIPMENT·Product code IOR·November 10, 2014

CLEAR VIEW UTERINE MANIPULATOR

FDA Adverse Event
Injury ·CLINICAL INNOVATIONS, INC.·Product code LKF·September 1, 2011

FLEXCATH STEERABLE SHEATH

FDA Adverse Event
Malfunction ·MEDTRONIC CRYOCATH LP·Product code DRA·July 22, 2013

IMP,TSV,MCOL MG,4.7MM,10M

FDA Adverse Event
Injury ·ZIMMER DENTAL·Product code DZE·January 13, 2022

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014